Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 25, 2026
Why Is Stablecoin Development Corporation (SDEV) Stock Up +18.6% Today?

Why Is Stablecoin Development Corporation (SDEV) Stock Up +18.6% Today?

Key Takeaways

  • Shares surged roughly 18.6% in Thursday's session, trading near $1.53 versus a prior close of $1.29.
  • Primary catalyst: a sharp rally in the SKY token, which SDEV holds as its core digital asset.
  • Institutional driver: Galaxy Digital's $100 million allocation to Sky Protocol's yield-bearing sUSDS token and its purchase of SKY reinforced institutional confidence in the ecosystem.
  • Structural theme: SDEV trades as a leveraged proxy for SKY, so token price moves translate directly into share-price swings.
  • What to watch: the direction of SKY's price, upcoming earnings in early November, and broader crypto-market sentiment.

Opening Summary

Stablecoin Development Corporation (SDEV), formerly NovaBay Pharmaceuticals, is an on-chain holding company that accumulates digital assets and participates in blockchain networks, with the Sky Protocol's SKY governance token as its core holding. On Thursday, shares of SDEV jumped approximately 18.6% to around $1.53, up from a prior closing price of $1.29, confirming a strong upward move. The rally was driven primarily by a surge in the price of SKY, which SDEV holds in large quantity, after Galaxy Digital deepened its institutional relationship with the Sky ecosystem.

Catalyst Breakdown: A SKY Token Rally Lifts the Stock

SDEV is fundamentally tied to the performance of SKY, the governance token of Sky Protocol (formerly MakerDAO). The company has reported holding roughly 2.3 billion SKY tokens, representing approximately 10% of the token's total supply, with the vast majority staked to earn rewards. Because the company's balance sheet is dominated by this single digital asset, its share price behaves like a leveraged position in SKY. When the token appreciates, the market value of the company's holdings rises, and investors bid the stock higher; when the token falls, the stock tends to fall with amplified intensity.

That dynamic was on full display Thursday, as SKY extended a multi-day advance following a run of bullish ecosystem news. The token's climb lifted the value of SDEV's underlying holdings, translating directly into double-digit share-price gains.

Galaxy Digital's Institutional Validation

The most immediate catalyst for the SKY rally was a disclosure that Galaxy Digital, a prominent digital-asset financial services firm, allocated $100 million of Sky Protocol's yield-bearing sUSDS token to its own corporate treasury using balance-sheet funds. Galaxy also approved sUSDS as eligible collateral across its institutional trading business—which carries an average loan book of roughly $1.4 billion—and acquired an undisclosed amount of SKY.

Market participants interpreted the move as a meaningful step in the institutionalization of the Sky ecosystem. By placing a yield-bearing stablecoin asset on its own balance sheet and enabling clients to post it as collateral while continuing to earn the Sky Savings Rate, Galaxy signaled confidence in Sky's on-chain savings and lending infrastructure. The news fueled a double-digit jump in SKY and, by extension, a surge in companies exposed to the token, including SDEV.

Sector Momentum and the Treasury-Company Trade

Beyond the Galaxy news, SDEV has benefited from a broader investor theme centered on publicly listed "treasury" vehicles that hold digital assets. Following the model popularized by companies that hold bitcoin on their balance sheets, a new cohort of listed firms—including holders of stablecoin-protocol governance tokens—has attracted speculative and momentum-driven buying as underlying token prices recover.

Research coverage has also added support. Analysts have framed Sky as a key issuer in the yield-bearing stablecoin space, and one major bank's digital-asset research team recently initiated coverage with a bullish multi-year outlook tied to growth in USDS circulation and value returned to SKY holders. Although SDEV itself carries no formal sell-side coverage, the positive institutional narrative around Sky has spilled over into the stock.

Market Context and Trading Activity

Trading in SDEV has been elevated and highly volatile in recent sessions. The stock has staged a rapid multi-day recovery from levels near $0.84, climbing through the $1.00 and $1.20 handles before accelerating into Thursday's advance. Volume has consistently run above the stock's trailing average, reflecting heightened participation from both retail and momentum traders drawn to the crypto-linked equity theme.

The move is largely idiosyncratic rather than reflective of the broad equity market. While SDEV surged, its behavior has tracked the crypto-asset complex and the specific news flow around Sky more closely than major stock indices. The stock's low float and thin institutional base also amplify price swings in either direction.

What Comes Next for SDEV

The outlook for SDEV remains closely tied to the price of SKY and the broader trajectory of the Sky ecosystem. Investors will be monitoring whether the institutional adoption signaled by Galaxy translates into sustained growth in USDS and sUSDS supply, and whether Sky's governance continues to direct value back to token holders through buybacks and staking rewards.

Company-specific events also loom. SDEV is expected to report earnings in early November, and any update on the size, staking yield, and fair value of its SKY holdings will be closely scrutinized. Key risks include sharp volatility in digital-asset prices, potential dilution from outstanding pre-funded warrants, and the concentration of the company's value in a single, highly volatile token. Traders should expect continued outsized daily swings.

Trending AI Robots

For investors seeking a systematic approach to fast-moving markets, Tickeron's Trending AI Robots page curates the platform's strongest-performing automated strategies under current conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, each varying by strategy, timeframe, performance metrics, and traded symbols. Only the top performers are featured in the curated Trending AI Robots section, making it a useful starting point for traders exploring algorithmic insights.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SDEV

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


SDEV's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for SDEV turned positive on September 18, 2026. Looking at past instances where SDEV's MACD turned positive, the stock continued to rise in 33 of 37 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 18, 2026. You may want to consider a long position or call options on SDEV as a result. In 57 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

SDEV moved above its 50-day moving average on September 22, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +24.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where SDEV advanced for three days, in 192 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The 10-day RSI Indicator for SDEV moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In 17 of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SDEV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

SDEV broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SDEV entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 6 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. SDEV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.513) is normal, around the industry mean (3.291). P/E Ratio (0.045) is within average values for comparable stocks, (27.023). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.343). SDEV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.080). P/S Ratio (16.639) is also within normal values, averaging (15.838).

The Tickeron Profit vs. Risk Rating rating for this company is 97 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SDEV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

Notable companies

The most notable companies in this group are Ares Capital Corp (NASDAQ:ARCC), WisdomTree (NYSE:WT), AMTD IDEA Group (NYSE:AMTD).

Industry description

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

Market Cap

The average market capitalization across the Investment Managers Industry is 8.72B. The market cap for tickers in the group ranges from 57 to 166.24B. BLK holds the highest valuation in this group at 166.24B. The lowest valued company is RSERF at 57.

High and low price notable news

The average weekly price growth across all stocks in the Investment Managers Industry was 3%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 17%. SVRN experienced the highest price growth at 198%, while MAAS experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Investment Managers Industry was 31%. For the same stocks of the Industry, the average monthly volume growth was 69% and the average quarterly volume growth was -18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 30
P/E Growth Rating: 54
Price Growth Rating: 53
SMR Rating: 67
Profit Risk Rating: 80
Seasonality Score: -46 (-100 ... +100)
View a ticker or compare two or three
SDEV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry InvestmentManagers

Industry
Biotechnology
Address
2000 Powell Street
Phone
+1 510 899-8800
Employees
4
Web
https://www.stabledev.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.